European Healthtech startup funding raised during April 2016.
In April 2016, 25 European Healthtech companies raised a combined €279M across 27 funding rounds, up 63.3% versus April 2015. UK led by capital raised, and Pontifax Funds was the most active investor. Data as of 23 Aug 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Oxford Nanopore Technologies | Growth/Late | Apr 2016 | €111M |
| MedDay | Series B | Apr 2016 | €34M |
| G-Therapeutics | Series A | Apr 2016 | €26M |
| STAT-Diagnostica | Series C |
3 exits · €628M disclosed.
| Valtech Cardio | Acquisition | Apr 2016 | €628M |
| Apr 2016 |
| €25M |
| Metabomed | Series A | Apr 2016 | €16M |
| G-Therapeutics | Debt | Apr 2016 | €10M |
| iSTAR Medical | Series B | Apr 2016 | €10M |
| Silk Biomaterials | Series A | Apr 2016 | €7.0M |
| Fora | Seed | Apr 2016 | €6.6M |
| Fire1foundry | Series B | Apr 2016 | €6.5M |
| TargEDys | Series A | Apr 2016 | €5.8M |
| Anergis | Series C | Apr 2016 | €4.6M |
| Sweetch | Series A | Apr 2016 | €3.1M |
| Thermosome | Grant | Apr 2016 | €2.7M |
| Biop Medical | Series A | Apr 2016 | €2.0M |
